AD	Alzheimer’s disease
AhR	aryl hydrocarbon receptor
Aβ	β-amyloid
BLT1	Leukotriene B4 receptor 1
CB1	cannabinoid receptor type 1
C5aR	complement component 5a receptor
CDCA	chenodeoxycholic acid
CHIPS	Chemotaxis inhibitory protein of S. aureus
CHO	Chinese hamster ovary
CsA	Cyclosporin A
CsH	Cyclosporin H
CXCR1	C-X-C motif chemokine receptor 1
CXCR4	C-X-C chemokine receptor type 4
DAMP	damage-associated molecular pattern
DCA	deoxycholic acid
EC50	half maximal effective concentration
E. coli	Escherichia coli
FAM3D	family with sequence similarity 3 member D
FPR	Formyl peptide receptor
GPCR	G protein-coupled receptor
H. pylori	Helicobacter pylori
HTS	high throughput screening
i-BOC	iso-butyloxycarbonyl
IC50	half maximal inhibitory concentration
Kd	dissociation constant
Ki	inhibitor constant
L. monocytogenes	Listeria monocytogenes
LXA4	lipoxin A4
μOR	μ-opioid receptor
oxLDL	oxidized low-density lipoprotein
PAMP	pathogen-associated molecular pattern
P2Y2R	P2Y purinoceptor 2
ROS	reactive oxygen species
SAA	serum amyloid A
SAR	structure-activity relationships
S. aureus	Staphylococcus aureus
t-Boc	tert-butyloxycarbonyl
uPA	Urokinase plasminogen activator
UG	Uteroglobin